跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,115 条关于
“ET-800”
全部
9,115
临床试验
6,049
药物
1,482
机构
60
资讯
1,524
去年
Eton Pharmaceuticals Poised for Growth with Expanding Rare Disease Portfolio and Pending FDA Approvals
去年
Eton Pharmaceuticals Receives FDA Approval for KHINDIVI, First Hydrocortisone Oral Solution for Pediatric Adrenal Insufficiency
3年前
Clinical Trials in Essential Thrombocythemia (ET)
去年
Eton Pharmaceuticals Secures Second Patent for Liquid Hydrocortisone Formulation ET-400
2年前
Eton Pharmaceuticals' ET-400 (Hydrocortisone Oral Solution) Receives FDA Acceptance
去年
Eton Pharmaceuticals' ET-600 Meets Bioequivalence Endpoints for Central Diabetes Insipidus Treatment
11年前
Ropeginterferon Alfa-2b Evaluated as Second-Line Therapy for High-Risk Essential Thrombocythemia in SURPASS-ET Trial
3年前
Ropeginterferon Alfa-2b Shows Promise in Hydroxyurea-Resistant Essential Thrombocythemia
去年
FDA Extends Review Period for Eton Pharmaceuticals' Rare Disease Drug ET-400
2年前
Eton Pharmaceuticals Submits NDA to FDA for ET-400 (Hydrocortisone Oral Solution)
第 1 页,共 153 页
上一页
下一页